DONG-A SOCIO HOLDINGS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115,900 KRW | +2.39% |
|
-2.61% | +14.75% |
| Sales 2024 * | 1,274B 921M | Sales 2025 * | 1,380B 998M | Capitalization | 724B 524M |
|---|---|---|---|---|---|
| Net income 2024 * | 67B 48.44M | Net income 2025 * | 78B 56.39M | EV / Sales 2024 * | 0.57 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.52 x |
| P/E ratio 2024 * |
11
x | P/E ratio 2025 * |
9.42
x | Employees | 5,530 |
| Yield 2024 * |
1.9% | Yield 2025 * |
1.9% | Free-Float | 50.99% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.39% | ||
| 1 week | -2.61% | ||
| Current month | -1.78% | ||
| 1 month | -0.77% | ||
| 3 months | +17.78% | ||
| 6 months | +9.03% | ||
| Current year | +14.75% |
1 week
110 000.00
115 900.00
1 month
110 000.00121 400.00
Current year
94 400.00121 400.00
1 year
76 800.00121 400.00
3 years
76 800.00140 000.00
5 years
66 700.00157 500.00
10 years
66 700.00247 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jong-Hyun Han
CEO | Chief Executive Officer | 56 | - |
Seong-Geun Park
DFI | Director of Finance/CFO | 56 | - |
Seong-Yeon Jeong
CMP | Compliance Officer | 42 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jung-Seok Kang
PRN | Corporate Officer/Principal | 59 | 95-12-31 |
Dong-Cheol Kim
BRD | Director/Board Member | 49 | - |
Jong-Hyun Han
CEO | Chief Executive Officer | 56 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | -1.38% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 115,900 | +2.39% | 4,873 |
| 24-04-17 | 113,200 | +0.35% | 1,810 |
| 24-04-16 | 112,800 | 0.00% | 5,716 |
| 24-04-15 | 112,800 | -2.34% | 3,178 |
| 24-04-12 | 115,500 | -2.94% | 4,110 |
End-of-day quote Korea S.E., April 17, 2024
More quotes
Dong-A Socio Holdings Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through five segments. The Medicine Manufacturing segment is engaged in the manufacture and sale of pharmaceuticals. The main pharmaceuticals include tonic medicines, cold medicines, raw material medicines. The Logistic segment is involved in the freight, courier, car transportation, freight warehousing and leasing business. The Packaging segment is engaged in manufacturing and sale of glass and glass products. The Holding Company segment is engaged in the provision of core companies and management consulting services. The Other segment is engaged in the production and sale of information and communication technology (IT) solutions and agricultural products, as well as real estate development business.
Sector
Pharmaceuticals
Calendar
2024-05-13
- Q1 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
115,900
KRW
Average target price
155,000
KRW
Spread / Average Target
+33.74%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +14.75% | 512M | |
| +27.97% | 676B | |
| +23.58% | 554B | |
| -7.02% | 349B | |
| +14.85% | 318B | |
| +6.25% | 291B | |
| +2.96% | 210B | |
| -0.41% | 204B | |
| -10.02% | 194B | |
| -11.81% | 144B |
- Stock Market
- Equities
- A000640 Stock
